They are like any investment counselor, paid or free, Cramer, GS, etc. You have to weigh WHAT the say and WHY against your own experience and common sense.
So based on that the long term prospects for Syngeva just don't look positive to me. Limited pipeline and patient base. Management that might be motivated to just milk the Trimeris cash.
You? Why?